HTB South

Dolutegravir-based dual therapy as switch option in multiple studies

Simon Collins, HIV i-Base

Two oral presentations and numerous posters included new data on using dolutegravir-based dual ART (many with 3TC) as a switch option for people currently on stable three-drug ART.

Full report at this link.

Links to other websites are current at date of posting but not maintained.